Global Veterinary Molecular Diagnostics Market Size study, by Product, Animal Type, Technology, Application, End-use and Regional Forecasts 2022-2032

Description

Global Veterinary Molecular Diagnostics Market is valued approximately at USD 1.12 billion in 2023 and is anticipated to grow with an impressive CAGR of more than 10.50% over the forecast period 2024-2032. The burgeoning field of veterinary molecular diagnostics is fundamentally reshaping how animal diseases are identified, monitored, and managed. With the surge in zoonotic diseases, heightened sensitivity to animal welfare, and the critical need for precision-driven veterinary care, molecular diagnostic tools have emerged as indispensable assets across both companion and livestock animal sectors. By leveraging technologies such as PCR, microarrays, and next-generation sequencing, these tools offer rapid, reliable, and highly specific insights into pathogen presence, genetic disorders, and antimicrobial resistance-all at the molecular level.

This surge in demand can largely be attributed to the increasing adoption of point-of-care diagnostics, a rise in pet ownership worldwide, and the exponential growth in livestock farming to meet global protein demands. Simultaneously, the veterinary healthcare community is gravitating toward preventive medicine, where early detection of diseases ensures timely intervention, thereby minimizing economic losses and curbing outbreaks. Advances in diagnostic accuracy, coupled with expanding availability of multiplex testing and portable molecular platforms, are further catalyzing this transition. These solutions are not only streamlining workflows in veterinary clinics and research labs but also empowering field veterinarians in remote or resource-constrained settings.

Yet, the path to widespread adoption is not without obstacles. The high costs associated with equipment and reagents, particularly in low-to-middle income regions, pose financial constraints. Additionally, a lack of skilled professionals and limited awareness regarding advanced molecular testing in rural veterinary settings slow down penetration. However, global initiatives for veterinary health infrastructure development and collaborative training programs are beginning to bridge these gaps. Moreover, continuous investments in R&D and integration with digital technologies such as AI and cloud-based diagnostic management systems are expected to democratize access and improve cost-efficiency in the long term.

As molecular diagnostics evolve, the focus is shifting toward next-gen innovations such as real-time pathogen monitoring, syndromic testing panels, and companion animal genomics. These trends are fueling strategic collaborations between biotech companies, veterinary hospitals, and academic institutions to deliver customized, species-specific diagnostic solutions. Notably, the market is experiencing a rise in demand for molecular diagnostics tailored to detect emerging and re-emerging animal diseases-supporting biosecurity across borders and aiding in the control of transboundary animal diseases that threaten global food security.

Regionally, North America holds a commanding position in the global veterinary molecular diagnostics market, backed by cutting-edge infrastructure, extensive companion animal expenditure, and robust regulatory frameworks. Europe follows closely, driven by proactive government policies surrounding animal health surveillance and precision livestock farming initiatives. Meanwhile, Asia Pacific is projected to grow at the highest CAGR over the forecast period, owing to rising disposable incomes, increasing pet adoption, and growing awareness of infectious disease control in high-density farming nations like China and India. Latin America and the Middle East & Africa are also witnessing a gradual uptake, primarily due to international funding and expanding veterinary education systems.

Major market player included in this report are:

IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Zoetis Inc.
Neogen Corporation
QIAGEN N.V.
Heska Corporation
Randox Laboratories Ltd.
Agilent Technologies Inc.
Bioneer Corporation
Creative Diagnostics
Biocheck B.V.
Eurofins Scientific
Biogal Galed Labs
VMRD, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product

Instruments
Reagents & Kits
Software & Services

By Animal Type

Companion Animals
- Dogs
- Cats
- Others
Livestock Animals
- Cattle
- Poultry
- Swine
- Others

By Technology

PCR (Polymerase Chain Reaction)
Microarrays
DNA Sequencing
Other Technologies

By Application

Pathogen Detection
Genetic Testing
Pharmacogenomics
Others

By End-use

Veterinary Hospitals & Clinics
Reference Laboratories
Research Institutes & Universities
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Veterinary Molecular Diagnostics Market Executive Summary

1.1. Global Veterinary Molecular Diagnostics Market Size & Forecast (2022 - 2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Animal Type
- 1.3.3. By Technology
- 1.3.4. By Application
- 1.3.5. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Veterinary Molecular Diagnostics Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply-Side Analysis
  - 2.3.3.1. Availability of Instruments & Reagents
  - 2.3.3.2. Laboratory Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Customer Perspective)
- 2.3.4. Demand-Side Analysis
  - 2.3.4.1. Regulatory Frameworks & Standards
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Animal Welfare & Biosecurity Considerations
  - 2.3.4.4. Practitioner Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Veterinary Molecular Diagnostics Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Adoption of Point-of-Care Molecular Diagnostics
- 3.1.2. Rising Pet Ownership and Companion Animal Expenditure
- 3.1.3. Growth in Livestock Farming to Meet Global Protein Demand
- 3.1.4. Shift toward Preventive Veterinary Medicine
- 3.1.5. Advances in Diagnostic Technologies (PCR, NGS, Microarrays)
3.2. Market Challenges
- 3.2.1. High Cost of Equipment and Reagents
- 3.2.2. Lack of Skilled Professionals in Rural/Resource-Constrained Settings
- 3.2.3. Limited Awareness of Advanced Molecular Testing in LMICs
- 3.2.4. Regulatory and Reimbursement Barriers
3.3. Market Opportunities
- 3.3.1. Global Health Initiatives and Veterinary Infrastructure Development
- 3.3.2. Integration with AI and Cloud-Based Diagnostic Management Systems
- 3.3.3. Development of Portable and Multiplex Testing Platforms
- 3.3.4. Next-Generation Innovations: Real-Time Pathogen Monitoring, Syndromic Panels
- 3.3.5. Companion Animal Genomics and Species-Specific Solutions

Chapter 4. Global Veterinary Molecular Diagnostics Market Industry Analysis

4.1. Porter's Five Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's Model
- 4.1.7. Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Veterinary Molecular Diagnostics Market Size & Forecasts by Product (2022 - 2032)

5.1. Segment Dashboard
5.2. Global Market: Instruments Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.3. Global Market: Reagents & Kits Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.4. Global Market: Software & Services Revenue Trend Analysis, 2022 & 2032 (USD Million)

Chapter 6. Global Veterinary Molecular Diagnostics Market Size & Forecasts by Animal Type (2022 - 2032)

6.1. Segment Dashboard
6.2. Companion Animals (Dogs, Cats, Others) Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.3. Livestock Animals (Cattle, Poultry, Swine, Others) Revenue Trend Analysis, 2022 & 2032 (USD Million)

Chapter 7. Global Veterinary Molecular Diagnostics Market Size & Forecasts by Technology, Application & End-use (2022 - 2032)

7.1. By Technology (PCR, Microarrays, DNA Sequencing, Other)
7.2. By Application (Pathogen Detection, Genetic Testing, Pharmacogenomics, Others)
7.3. By End-use (Veterinary Hospitals & Clinics, Reference Laboratories, Research Institutes & Universities, Others)

Chapter 8. Global Veterinary Molecular Diagnostics Market Size & Forecasts by Region (2022 - 2032)

8.1. North America
- 8.1.1. U.S.
  - 8.1.1.1. By Product Breakdown, 2022 - 2032
  - 8.1.1.2. By Animal Type Breakdown, 2022 - 2032
  - 8.1.1.3. By Technology/Application/End-use Breakdown, 2022 - 2032
- 8.1.2. Canada
8.2. Europe
- 8.2.1. U.K.
- 8.2.2. Germany
- 8.2.3. France
- 8.2.4. Spain
- 8.2.5. Italy
- 8.2.6. Rest of Europe
8.3. Asia Pacific
- 8.3.1. China
- 8.3.2. India
- 8.3.3. Japan
- 8.3.4. Australia
- 8.3.5. South Korea
- 8.3.6. Rest of Asia Pacific
8.4. Latin America
- 8.4.1. Brazil
- 8.4.2. Mexico
- 8.4.3. Rest of Latin America
8.5. Middle East & Africa
- 8.5.1. Saudi Arabia
- 8.5.2. South Africa
- 8.5.3. Rest of Middle East & Africa

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. IDEXX Laboratories, Inc.
- 9.1.2. Thermo Fisher Scientific Inc.
- 9.1.3. Bio-Rad Laboratories, Inc.
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. IDEXX Laboratories, Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Thermo Fisher Scientific Inc.
- 9.3.3. Bio-Rad Laboratories, Inc.
- 9.3.4. Zoetis Inc.
- 9.3.5. Neogen Corporation
- 9.3.6. QIAGEN N.V.
- 9.3.7. Heska Corporation
- 9.3.8. Randox Laboratories Ltd.
- 9.3.9. Agilent Technologies Inc.
- 9.3.10. Bioneer Corporation
- 9.3.11. Creative Diagnostics
- 9.3.12. Biocheck B.V.
- 9.3.13. Eurofins Scientific
- 9.3.14. Biogal Galed Labs
- 9.3.15. VMRD, Inc.

Chapter 10. Research Process

10.1. Research Methodology
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes